These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1813 related articles for article (PubMed ID: 30322817)

  • 21. Prospective trial comparing full-field digital mammography (FFDM) versus combined FFDM and tomosynthesis in a population-based screening programme using independent double reading with arbitration.
    Skaane P; Bandos AI; Gullien R; Eben EB; Ekseth U; Haakenaasen U; Izadi M; Jebsen IN; Jahr G; Krager M; Hofvind S
    Eur Radiol; 2013 Aug; 23(8):2061-71. PubMed ID: 23553585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2).
    Tagliafico AS; Mariscotti G; Valdora F; Durando M; Nori J; La Forgia D; Rosenberg I; Caumo F; Gandolfo N; Sormani MP; Signori A; Calabrese M; Houssami N
    Eur J Cancer; 2018 Nov; 104():39-46. PubMed ID: 30316869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective study aiming to compare 2D mammography and tomosynthesis + synthesized mammography in terms of cancer detection and recall. From double reading of 2D mammography to single reading of tomosynthesis.
    Romero Martín S; Raya Povedano JL; Cara García M; Santos Romero AL; Pedrosa Garriguet M; Álvarez Benito M
    Eur Radiol; 2018 Jun; 28(6):2484-2491. PubMed ID: 29294150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-view and single-view tomosynthesis versus full-field digital mammography: high-resolution X-ray imaging observer study.
    Wallis MG; Moa E; Zanca F; Leifland K; Danielsson M
    Radiology; 2012 Mar; 262(3):788-96. PubMed ID: 22274840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of screen-detected cancers following concordant or discordant recalls at blinded double reading in biennial digital screening mammography.
    Coolen AMP; Lameijer JRC; Voogd AC; Louwman MWJ; Strobbe LJ; Tjan-Heijnen VCG; Duijm LEM
    Eur Radiol; 2019 Jan; 29(1):337-344. PubMed ID: 29943181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Five Consecutive Years of Screening with Digital Breast Tomosynthesis: Outcomes by Screening Year and Round.
    Conant EF; Zuckerman SP; McDonald ES; Weinstein SP; Korhonen KE; Birnbaum JA; Tobey JD; Schnall MD; Hubbard RA
    Radiology; 2020 May; 295(2):285-293. PubMed ID: 32154771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digital Mammography versus Breast Tomosynthesis: Impact of Breast Density on Diagnostic Performance in Population-based Screening.
    Østerås BH; Martinsen ACT; Gullien R; Skaane P
    Radiology; 2019 Oct; 293(1):60-68. PubMed ID: 31407968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digital Mammography versus Digital Mammography Plus Tomosynthesis in Breast Cancer Screening: The Oslo Tomosynthesis Screening Trial.
    Skaane P; Bandos AI; Niklason LT; Sebuødegård S; Østerås BH; Gullien R; Gur D; Hofvind S
    Radiology; 2019 Apr; 291(1):23-30. PubMed ID: 30777808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of one-view breast tomosynthesis versus two-view mammography in diagnostic workup of women with clinical signs and symptoms and in women recalled from screening.
    Waldherr C; Cerny P; Altermatt HJ; Berclaz G; Ciriolo M; Buser K; Sonnenschein MJ
    AJR Am J Roentgenol; 2013 Jan; 200(1):226-31. PubMed ID: 23255766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.
    Houssami N; Bernardi D; Caumo F; Brunelli S; Fantò C; Valentini M; Romanucci G; Gentilini MA; Zorzi M; Macaskill P
    Breast; 2018 Apr; 38():150-153. PubMed ID: 29328943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of breast cancer screening using digital breast tomosynthesis: results from the prospective population-based Oslo Tomosynthesis Screening Trial.
    Skaane P; Sebuødegård S; Bandos AI; Gur D; Østerås BH; Gullien R; Hofvind S
    Breast Cancer Res Treat; 2018 Jun; 169(3):489-496. PubMed ID: 29429017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of real-life use of artificial intelligence as support for human reading in a population-based breast cancer screening program with mammography and tomosynthesis.
    Elías-Cabot E; Romero-Martín S; Raya-Povedano JL; Brehl AK; Álvarez-Benito M
    Eur Radiol; 2024 Jun; 34(6):3958-3966. PubMed ID: 37975920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. False positives in breast cancer screening with one-view breast tomosynthesis: An analysis of findings leading to recall, work-up and biopsy rates in the Malmö Breast Tomosynthesis Screening Trial.
    Lång K; Nergården M; Andersson I; Rosso A; Zackrisson S
    Eur Radiol; 2016 Nov; 26(11):3899-3907. PubMed ID: 26943342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy and recall rates for digital mammography and digital mammography combined with one-view and two-view tomosynthesis: results of an enriched reader study.
    Rafferty EA; Park JM; Philpotts LE; Poplack SP; Sumkin JH; Halpern EF; Niklason LT
    AJR Am J Roentgenol; 2014 Feb; 202(2):273-81. PubMed ID: 24450665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: results of a multicenter, multireader trial.
    Rafferty EA; Park JM; Philpotts LE; Poplack SP; Sumkin JH; Halpern EF; Niklason LT
    Radiology; 2013 Jan; 266(1):104-13. PubMed ID: 23169790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AI-based Strategies to Reduce Workload in Breast Cancer Screening with Mammography and Tomosynthesis: A Retrospective Evaluation.
    Raya-Povedano JL; Romero-Martín S; Elías-Cabot E; Gubern-Mérida A; Rodríguez-Ruiz A; Álvarez-Benito M
    Radiology; 2021 Jul; 300(1):57-65. PubMed ID: 33944627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recall Rate Reduction with Tomosynthesis During Baseline Screening Examinations: An Assessment From a Prospective Trial.
    Sumkin JH; Ganott MA; Chough DM; Catullo VJ; Zuley ML; Shinde DD; Hakim CM; Bandos AI; Gur D
    Acad Radiol; 2015 Dec; 22(12):1477-82. PubMed ID: 26391857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical performance metrics of 3D digital breast tomosynthesis compared with 2D digital mammography for breast cancer screening in community practice.
    Greenberg JS; Javitt MC; Katzen J; Michael S; Holland AE
    AJR Am J Roentgenol; 2014 Sep; 203(3):687-93. PubMed ID: 24918774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of breast cancers detected in the Verona screening program following transition to digital breast tomosynthesis screening with cancers detected at digital mammography screening.
    Caumo F; Romanucci G; Hunter K; Zorzi M; Brunelli S; Macaskill P; Houssami N
    Breast Cancer Res Treat; 2018 Jul; 170(2):391-397. PubMed ID: 29557996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 91.